Bridging the gap between research, harm reduction, treatment and people living with hepatitis C

Elimination of hepatitis C asks for Community Involvement

With new medicines now available an opportunity exists to completely eradicate hepatitis C.  However, it will require pharmaceutical companies, governments, doctors, and health providers to come together to ensure that these medications are quickly available to all. A crucial factor for success will be the involvement of people living with hepatitis C.

The implementation of harm reduction and low threshold community based services, such as providing access to testing and treatment as well as effective prevention interventions will be critical to ensure the treatment of high risk groups such as people who inject drugs, men having sex with men and immigrants.


The 2nd HEP-C Community Summit organised by Correlation European Harm Reduction Network will bring together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss and to develop an enduring cooperation for building the road to HCV elimination.

The summit is organised in close cooperation with the International Network of Hepatitis in Substance Users (INHSU), which organizes 7th International Symposium on Hepatitis Care in Substance Users in Cascais (close to Lisbon) between 19 – 21 September 2018. As part of this conference, INHSU usually works together with community-based organizations to hold a Community Day prior to the conference. In 2018, INHSU is partnering with the HEP-C Community Summit to organize this day. We encourage participants to take part in  both the HEP-C Community Summit and the INHSU 2018 conference to enable information and knowledge exchange and to create linkages between community, advocates, researchers, practitioners, and policy makers to enhance HCV elimination efforts.

The HEP-C Community Summit will highlight the needs, current gaps and opportunities to make HCV treatment available for all people. The summit will also present and discuss community approaches for testing and treatment for HCV (and other diseases), and discuss and agree on further community action and advocacy steps.

As a result of the meeting, common advocacy activities will be agreed on between involved networks and organisations.


Programme Committee

APDES, José Queiroz

CASO, Rui Coimbra Morias

COALITION PLUS, Maria Donatelli


EATG, Mario Cascio

ELPA, Tatjana Reic

EuroNPUD, Tonny van Montfoort

EHRA, Ganna Dovbakh

GAT, Daniel Simões

IDHDP, Sebastian Saville

INHSU, Jude Byrne

INPUD, Judy Chang




7 + 4 =

Your contact information will only be stored for the purpose of sending information on the conference. Your personal data can be deleted at any time upon request.

Correlation European Harm Reduction Network

tel. +31 20 570 7826 (direct)

c/o Foundation


Droogbak 1d

1013 GE Amsterdam

The Netherlands